相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Selective induction of P-glycoprotein at the CNS barriers during symptomatic stage of an ALS animal model
Gary N. Y. Chan et al.
NEUROSCIENCE LETTERS (2017)
Current Therapy of Drugs in Amyotrophic Lateral Sclerosis
Haiyan Lu et al.
CURRENT NEUROPHARMACOLOGY (2016)
Astrocytes Drive Upregulation of the Multidrug Resistance Transporter ABCB1 (P-Glycoprotein) in Endothelial Cells of the Blood- Brain Barrier in Mutant Superoxide Dismutase 1-Linked Amyotrophic Lateral Sclerosis
Hisham Qosa et al.
GLIA (2016)
LPA1 Mediates Antidepressant-Induced ERK1/2 Signaling and Protection from Oxidative Stress in Glial Cells
Maria C. Olianas et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2016)
Antidepressants activate the lysophosphatidic acid receptor LPA1 to induce insulin-like growth factor-I receptor transactivation, stimulation of ERK1/2 signaling and cell proliferation in CHO-K1 fibroblasts
Maria C. Olianas et al.
BIOCHEMICAL PHARMACOLOGY (2015)
ABC transporter-driven pharmacoresistance in Amyotrophic Lateral Sclerosis
Michael Jablonski et al.
BRAIN RESEARCH (2015)
Lysophospholipid mediators in the vasculature
Paul Mueller et al.
EXPERIMENTAL CELL RESEARCH (2015)
Lysophosphatidic Acid Signaling in the Nervous System
Yun C. Yung et al.
NEURON (2015)
Role of Rho kinase in lysophosphatidic acid-induced altering of blood-brain barrier permeability
Ying Yu et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2014)
Nrf2 Upregulates ATP Binding Cassette Transporter Expression and Activity at the Blood-Brain and Blood-Spinal Cord Barriers
Xueqian Wang et al.
JOURNAL OF NEUROSCIENCE (2014)
Inhibiting drug efflux transporters improves efficacy of ALS therapeutics
Michael R. Jablonski et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2014)
Rapid and reversible enhancement of blood-brain barrier permeability using lysophosphatidic acid
Ngoc H. On et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2013)
Blood-brain barrier structure and function and the challenges for CNS drug delivery
N. Joan Abbott
JOURNAL OF INHERITED METABOLIC DISEASE (2013)
Selective increase of two ABC drug efflux transporters at the blood-spinal cord barrier suggests induced pharmacoresistance in ALS
Michael R. Jablonski et al.
NEUROBIOLOGY OF DISEASE (2012)
Targeting blood-brain barrier sphingolipid signaling reduces basal P-glycoprotein activity and improves drug delivery to the brain
Ronald E. Cannon et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Autotaxin and LPA receptor signaling in cancer
Anna J. S. Houben et al.
CANCER AND METASTASIS REVIEWS (2011)
LPA Receptors: Subtypes and Biological Actions
Ji Woong Choi et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY (2010)
Rapid, Reversible Modulation of Blood-Brain Barrier P-Glycoprotein Transport Activity by Vascular Endothelial Growth Factor
Brian T. Hawkins et al.
JOURNAL OF NEUROSCIENCE (2010)
Constitutive Androstane Receptor-Mediated Up-Regulation of ATP-Driven Xenobiotic Efflux Transporters at the Blood-Brain Barrier
Xueqian Wang et al.
MOLECULAR PHARMACOLOGY (2010)
Structure and function of the blood-brain barrier
N. Joan Abbott et al.
NEUROBIOLOGY OF DISEASE (2010)
P-glycoprotein expression and function are increased in an animal model of amyotrophic lateral sclerosis
Aline Milane et al.
NEUROSCIENCE LETTERS (2010)
Lysophosphatidic acid (LPA) receptors: Signaling properties and disease relevance
Mu-En Lin et al.
PROSTAGLANDINS & OTHER LIPID MEDIATORS (2010)
Diesel exhaust particles induce oxidative stress, proinflammatory signaling, and P-glycoprotein up-regulation at the blood-brain barrier
Anika M. S. Hartz et al.
FASEB JOURNAL (2008)
Seizure-induced up-regulation of P-glycoprotein at the blood-brain barrier through glutamate and cyclooxygenase-2 signaling
Bjoern Bauer et al.
MOLECULAR PHARMACOLOGY (2008)
Identification of early disease progression in an ALS rat model
Jason R. Thonhoff et al.
NEUROSCIENCE LETTERS (2007)
Tumor necrosis factor α and endothelin-1 increase P-glycoprotein expression and transport activity at the blood-brain barrier
Bjorn Bauer et al.
MOLECULAR PHARMACOLOGY (2007)
Drug transporters in the epileptic brain
Wolfgang Loescher
EPILEPSIA (2007)
Blood-brain barrier penetration and pharmacokinetics of amitriptyline and its metabolites in p-glycoprotein (abcb1ab) knock-out mice and controls
Manfred Uhr et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2007)
Inhibition of multidrug resistance transporter-1 facilitates neuroprotective therapies after focal cerebral ischemia
A Spudich et al.
NATURE NEUROSCIENCE (2006)
Disease progression of human SOD1 (G93A) transgenic ALS model rats
A Matsumoto et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2006)
Drug resistance in brain diseases and the role of drug efflux transporters
W Löscher et al.
NATURE REVIEWS NEUROSCIENCE (2005)
Rapid regulation of P-glycoprotein at the blood-brain barrier by endothelin-1
AMS Hartz et al.
MOLECULAR PHARMACOLOGY (2004)
Treatment of primary insomnia
EN Ringdahl et al.
JOURNAL OF THE AMERICAN BOARD OF FAMILY PRACTICE (2004)
Microglial activation state and lysophospholipid acid receptor expression
CS Tham et al.
INTERNATIONAL JOURNAL OF DEVELOPMENTAL NEUROSCIENCE (2003)
Expression and function of lysophosphatidic acid receptors in cultured rodent microglial cells
T Möller et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Xenobiotic transport across isolated brain microvessels studied by confocal microscopy
DS Miller et al.
MOLECULAR PHARMACOLOGY (2000)
分享论文
